Company Announcements

Transaction in Own Shares

Source: RNS
RNS Number : 9331O
Centrica PLC
03 February 2023
 

 

Transactions in own shares

 

 

Centrica plc

3 February 2023

 

 

Centrica plc announces that today it purchased (through UBS AG London Branch) 3,729,776 Centrica plc ordinary shares of 6 14/81 pence each at a price of 95.6492 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's buyback programme (details of which were as announced on 15 November 2022) and effected in accordance with the non-discretionary share repurchase agreement entered into with UBS AG London Branch, as announced on 15 November 2022. 

 

Since 15 November 2022, Centrica has purchased 99,939,983 ordinary shares at a cost (excluding dealing and associated costs) of £94,729,154.69.

 

Following the above purchase, Centrica plc holds 99,888,135 ordinary shares in treasury, and has 5,807,958,003 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by UBS AG London Branch is set out below.

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

UBS AG London Branch

Intermediary Code:

UBSWGB2L

Currency:

GBP

Aggregated information

Date of purchase:              

3 February 2023

Number of ordinary shares purchased:

3,729,776

Highest price paid

98p

Lowest price paid

93.78p

Volume weighted average price paid per share (p):

95.6492p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by UBS AG London Branch, as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

 http://www.rns-pdf.londonstockexchange.com/rns/9331O_1-2023-2-3.pdf

 

 

END

 

Enquiries:

Investors and Analysts
T: 01753 494900
E: ir@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSZZGGZNFLGFZM